Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Keros Therapeutics (KROS) Gross Profit: 2019-2024

Historic Gross Profit for Keros Therapeutics (KROS) over the last 6 years, with Dec 2024 value amounting to $3.5 million.

  • Keros Therapeutics' Gross Profit rose 3575.77% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.7 million, marking a year-over-year increase of 37798.31%. This contributed to the annual value of $3.5 million for FY2024, which is 2250.99% up from last year.
  • Latest data reveals that Keros Therapeutics reported Gross Profit of $3.5 million as of FY2024, which was up 2,250.99% from $151,000 recorded in FY2023.
  • Over the past 5 years, Keros Therapeutics' Gross Profit peaked at $18.0 million during FY2021, and registered a low of -$6,000 during FY2020.
  • For the 3-year period, Keros Therapeutics' Gross Profit averaged around $1.2 million, with its median value being $151,000 (2023).
  • As far as peak fluctuations go, Keros Therapeutics' Gross Profit crashed by 100.06% in 2020, and later skyrocketed by 300,100.00% in 2021.
  • Over the past 5 years, Keros Therapeutics' Gross Profit (Yearly) stood at -$6,000 in 2020, then spiked by 300,100.00% to $18.0 million in 2021, then crashed by 100.01% to -$1,000 in 2022, then skyrocketed by 15,200.00% to $151,000 in 2023, then surged by 2,250.99% to $3.5 million in 2024.